Gene: TATDN1
Official Full Name: TatD DNase domain containing 1provided by HGNC
Gene Summary: Predicted to enable 3'-5'-DNA exonuclease activity. Predicted to be involved in DNA metabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25297 | TATDN1 Knockout cell line (HeLa) | Human | TATDN1 | 1:3~1:6 | Negative | Online Inquiry |
KO25298 | TATDN1 Knockout cell line (HCT 116) | Human | TATDN1 | 1:2~1:4 | Negative | Online Inquiry |
KO25299 | TATDN1 Knockout cell line (HEK293) | Human | TATDN1 | 1:3~1:6 | Negative | Online Inquiry |
KO25300 | TATDN1 Knockout cell line (A549) | Human | TATDN1 | 1:3~1:4 | Negative | Online Inquiry |
TATDN1 Gene Knockout Cell Lines are specialized cellular models engineered to exhibit the absence of the TATDN1 gene, which encodes a protein implicated in various cellular processes, including DNA repair and cellular signaling pathways. These knockout cell lines are generated using advanced gene-editing technologies such as CRISPR-Cas9, enabling precise modifications that provide invaluable tools for investigating the functional role of the TATDN1 gene in both normal and pathological states.
The primary function of TATDN1 Gene Knockout Cell Lines lies in their ability to facilitate in-depth studies into the molecular mechanisms of diseases where TATDN1 plays a pivotal role. Researchers can examine the consequences of TATDN1 loss on cellular functions such as proliferation, apoptosis, and response to DNA damage, thus shedding light on its implications in cancer research and therapeutic targeting. Moreover, these cell lines serve as a platform for the assessment of pharmacological compounds aimed at modulating pathways influenced by TATDN1.
The scientific importance of these knockout cell lines extends into both basic and applied research contexts, including drug development and the validation of therapeutic targets. They provide an essential counterpart to wild-type cell lines, granting distinct advantages in elucidating gene function without the interference of wild-type protein expression.
In terms of unique selling points, the TATDN1 Gene Knockout Cell Lines offer specificity and reduced variability compared to conventional approaches, minimizing off-target effects commonly associated with chemical inhibitors. This precision allows for more accurate interpretations of experimental results. Furthermore, our cell lines are rigorously validated for genetic modification and functional assays, ensuring reliability in research outputs.
For researchers and clinicians focused on understanding TATDN1-related pathways or exploring novel therapeutic avenues, our TATDN1 Gene Knockout Cell Lines represent a robust and versatile resource. They enable enhanced experimental design and facilitate groundbreaking discoveries in genetics and molecular biology.
Our company is dedicated to advancing the field of biotechnology through high-quality biological products and expertise. With years of experience in genetic engineering, we are committed to providing researchers with the essential tools they need to push the boundaries of scientific exploration.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.